ANTICIPATION, OPTIMIZATION AND ORIENTATION in the treatment with biological drugs of patients with cancer or chronic inflammatory diseases.
Currently, about 70% of new drugs are biological and it seems to be crucial to accurately and objectively assess the patient’s response to a treatment.
Theradiag’s Lisa Tracker kits allow the implementation of a personalized treatment for each patient, controlling the effectiveness of treatment, anticipating lack of therapeutic response and other side effects inherent in these biotherapies.
Lisa Tracker kits thus constitute a new approach in monitoring these bioterapies and a significant advance in developing an individualised and responsible treatment.
Theradiag is the first in vitro diagnostic company to offer the complete solution for patients undergoing biological therapy. LISA TRACKER Brochure
For more information: email@example.com